BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20123952)

  • 1. Neurodevelopmental outcome of acute bilirubin encephalopathy.
    Mukhopadhyay K; Chowdhary G; Singh P; Kumar P; Narang A
    J Trop Pediatr; 2010 Oct; 56(5):333-6. PubMed ID: 20123952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kernicterus in preterm infants.
    Okumura A; Kidokoro H; Shoji H; Nakazawa T; Mimaki M; Fujii K; Oba H; Shimizu T
    Pediatrics; 2009 Jun; 123(6):e1052-8. PubMed ID: 19433515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004).
    Johnson L; Bhutani VK; Karp K; Sivieri EM; Shapiro SM
    J Perinatol; 2009 Feb; 29 Suppl 1():S25-45. PubMed ID: 19177057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more.
    Newman TB; Liljestrand P; Jeremy RJ; Ferriero DM; Wu YW; Hudes ES; Escobar GJ;
    N Engl J Med; 2006 May; 354(18):1889-900. PubMed ID: 16672700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe neonatal hyperbilirubinemia and adverse short-term consequences in Baghdad, Iraq.
    Hameed NN; Na' Ma AM; Vilms R; Bhutani VK
    Neonatology; 2011; 100(1):57-63. PubMed ID: 21212697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial brain MRI and ultrasound findings: relation to gestational age, bilirubin level, neonatal neurologic status and neurodevelopmental outcome in infants at risk of kernicterus.
    Gkoltsiou K; Tzoufi M; Counsell S; Rutherford M; Cowan F
    Early Hum Dev; 2008 Dec; 84(12):829-38. PubMed ID: 18851903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term outcome of severe neonatal nonhemolytic hyperbilirubinemia.
    Wong V; Chen WX; Wong KY
    J Child Neurol; 2006 Apr; 21(4):309-15. PubMed ID: 16900927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversibility of acute intermediate phase bilirubin encephalopathy.
    Hansen TW; Nietsch L; Norman E; Bjerre JV; Hascoet JM; Mreihil K; Ebbesen F
    Acta Paediatr; 2009 Oct; 98(10):1689-94. PubMed ID: 19583707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia.
    Harris MC; Bernbaum JC; Polin JR; Zimmerman R; Polin RA
    Pediatrics; 2001 May; 107(5):1075-80. PubMed ID: 11331689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient bilirubin encephalopathy and apnea of prematurity in 28 to 32 weeks gestational age infants.
    Amin SB; Charafeddine L; Guillet R
    J Perinatol; 2005 Jun; 25(6):386-90. PubMed ID: 15843815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperbilirubinemia in preterm infants and neurodevelopmental outcome at 2 years of age: results of a national collaborative survey.
    van de Bor M; van Zeben-van der Aa TM; Verloove-Vanhorick SP; Brand R; Ruys JH
    Pediatrics; 1989 Jun; 83(6):915-20. PubMed ID: 2471139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exchange transfusion in infants with extreme hyperbilirubinemia: an experience from a developing country.
    Salas AA; Mazzi E
    Acta Paediatr; 2008 Jun; 97(6):754-8. PubMed ID: 18422806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic bilirubin encephalopathy: diagnosis and outcome.
    Shapiro SM
    Semin Fetal Neonatal Med; 2010 Jun; 15(3):157-63. PubMed ID: 20116355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau and S100B proteins as biochemical markers of bilirubin-induced neurotoxicity in term neonates.
    Okumus N; Turkyilmaz C; Onal EE; Atalay Y; Serdaroglu A; Elbeg S; Koc E; Deda G; Cansu A; Gunduz B
    Pediatr Neurol; 2008 Oct; 39(4):245-52. PubMed ID: 18805362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence and outcome of bilirubin encephalopathy in Nigeria: a bi-centre study.
    Ogunlesi TA; Dedeke IO; Adekanmbi AF; Fetuga MB; Ogunfowora OB
    Niger J Med; 2007; 16(4):354-9. PubMed ID: 18080595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigintiphobia, unbound bilirubin, and auditory brainstem responses.
    Funato M; Tamai H; Shimada S; Nakamura H
    Pediatrics; 1994 Jan; 93(1):50-3. PubMed ID: 8265323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute neurological findings in a national cohort of neonates with severe neonatal hyperbilirubinemia.
    Sgro M; Campbell D; Barozzino T; Shah V
    J Perinatol; 2011 Jun; 31(6):392-6. PubMed ID: 21151009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unbound bilirubin concentration is associated with abnormal automated auditory brainstem response for jaundiced newborns.
    Ahlfors CE; Parker AE
    Pediatrics; 2008 May; 121(5):976-8. PubMed ID: 18450902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One year outcome of babies with severe neonatal hyperbilirubinemia and reversible abnormality in brainstem auditory evoked responses.
    Deorari AK; Singh M; Ahuja GK; Bisht MS; Verma A; Paul VK; Tandon DA
    Indian Pediatr; 1994 Aug; 31(8):915-21. PubMed ID: 7883343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND).
    Shapiro SM
    J Perinatol; 2005 Jan; 25(1):54-9. PubMed ID: 15578034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.